| Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Net loss | -1 | 0 | 2 | 1 | -3 | -6 | -1 | 3 | 8 | 4 | -8 | -144 | -88 |
---|
Depreciation | 2 | 4 | 4 | - | 7 | 16 | 16 | 16 | 20 | 26 | 30 | 35 | 37 |
---|
Amortization of intangibles | - | 0 | 0 | 0 | 0 | 7 | 7 | 6 | 10 | 10 | 23 | 34 | 35 |
---|
Non-cash stock-based compensation | - | - | - | 1 | 3 | 5 | 6 | 7 | 10 | 10 | 22 | 25 | 25 |
---|
Operating Lease, Expense | - | - | - | - | - | - | - | - | 6 | 6 | 9 | 10 | 9 |
---|
Amortization of Debt Discount (Premium) | - | - | - | - | - | - | - | - | - | 4 | 3 | 3 | 3 |
---|
Amortization of debt issuance costs | 0 | 0 | 0 | 0 | - | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
---|
Loss on debt extinguishment | - | - | - | - | - | -1 | - | - | -1 | -1 | - | - | - |
---|
Gain on investment in and loan receivable from non-consolidated affiliate, net | - | - | - | - | - | - | - | - | - | - | 109 | - | - |
---|
Loss on termination of cash flow hedge | - | - | - | - | - | - | - | - | - | -4 | - | - | - |
---|
Interest on loan receivable from non-consolidated affiliate | - | - | - | - | - | - | - | - | - | - | 0 | - | - |
---|
Gain on investment in and loan receivable from non-consolidated affiliate, net | - | - | - | - | - | - | - | - | - | - | 109 | - | - |
---|
Loss on disposal of assets | - | - | - | - | - | - | - | - | - | - | - | -3 | -0 |
---|
Interest on loan receivable from non-consolidated affiliate | - | - | - | - | - | - | - | - | - | - | 0 | - | - |
---|
Gain on sale of assets held for sale | - | - | - | - | - | - | - | - | - | - | - | 2 | - |
---|
Loss on disposal of assets | - | - | - | - | - | - | - | - | - | - | - | -3 | -0 |
---|
Impairment of long-lived assets | - | - | - | - | - | - | - | - | - | - | - | 1 | 2 |
---|
Gain on sale of assets held for sale | - | - | - | - | - | - | - | - | - | - | - | 2 | - |
---|
Polymerase Chain Reaction Testing, Exit Costs, COVID-19 | - | - | - | - | - | - | - | - | - | - | 6 | - | - |
---|
Impairment of long-lived assets | - | - | - | - | - | - | - | - | - | - | - | 1 | 2 |
---|
Other non-cash items | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
---|
Polymerase Chain Reaction Testing, Exit Costs, COVID-19 | - | - | - | - | - | - | - | - | - | - | 6 | - | - |
---|
Accounts receivable, net | 5 | 9 | 7 | 3 | 3 | 18 | 24 | -0 | 17 | 13 | 5 | 8 | 12 |
---|
Inventories | 0 | 1 | 0 | 0 | 1 | 1 | 1 | -1 | 6 | 15 | -2 | 1 | 0 |
---|
Prepaid lease asset | - | - | - | - | - | - | - | - | - | 20 | 5 | - | - |
---|
Prepaid and other assets | - | -0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 10 | 2 | 1 | - |
---|
Prepaid and other assets | - | - | - | - | - | - | - | - | - | - | - | - | 3 |
---|
Operating lease liabilities | - | - | - | - | - | - | - | - | - | - | - | -9 | -8 |
---|
Increase (Decrease) in Income Taxes | - | - | - | - | - | - | - | - | - | - | - | -16 | - |
---|
Deferred income tax liabilities, net | - | - | - | - | - | - | - | - | - | - | - | - | 11 |
---|
Accounts payable, accrued and other liabilities | 2 | 1 | 1 | 2 | 6 | -2 | -5 | 13 | -9 | -4 | 5 | 3 | -5 |
---|
Accrued compensation | - | - | - | - | - | - | - | - | - | - | - | - | 13 |
---|
Accounts payable, accrued and other liabilities | 2 | 1 | 1 | 2 | 6 | -2 | -5 | 13 | -9 | -4 | 5 | 3 | -5 |
---|
Other non-cash items | - | - | - | - | - | - | - | - | - | -1 | -3 | -2 | - |
---|
Accounts receivable, net | 5 | 9 | 7 | 3 | 3 | 18 | 24 | -0 | 17 | 13 | 5 | 8 | 12 |
---|
Inventories | 0 | 1 | 0 | 0 | 1 | 1 | 1 | -1 | 6 | 15 | -2 | 1 | 0 |
---|
Prepaid lease asset | - | - | - | - | - | - | - | - | - | 20 | 5 | - | - |
---|
Prepaid and other assets | - | -0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 10 | 2 | 1 | - |
---|
Prepaid and other assets | - | - | - | - | - | - | - | - | - | - | - | - | 3 |
---|
Operating lease liabilities | - | - | - | - | - | - | - | - | - | - | - | -9 | -8 |
---|
Increase (Decrease) in Income Taxes | - | - | - | - | - | - | - | - | - | - | - | -16 | - |
---|
Deferred income tax liabilities, net | - | - | - | - | - | - | - | - | - | - | - | - | 11 |
---|
Accounts payable, accrued and other liabilities | 2 | 1 | 1 | 2 | 6 | -2 | -5 | 13 | -9 | -4 | 5 | 3 | -5 |
---|
Accrued compensation | - | - | - | - | - | - | - | - | - | - | - | - | 13 |
---|
Accounts payable, accrued and other liabilities | 2 | 1 | 1 | 2 | 6 | -2 | -5 | 13 | -9 | -4 | 5 | 3 | -5 |
---|
Net cash used in operating activities | 0 | -0 | 2 | - | - | - | - | - | 23 | 1 | -27 | -66 | -2 |
---|
Net cash used in operating activities | 0 | -0 | 2 | - | - | - | - | - | 23 | 1 | -27 | -66 | -2 |
---|
Purchases of marketable securities | - | - | - | - | - | - | - | - | - | 73 | 197 | 98 | 7 |
---|
Proceeds from maturities of marketable securities | - | - | - | - | - | - | - | - | - | 5 | 63 | 117 | 112 |
---|
Purchases of property and equipment | 1 | 3 | 2 | 4 | 2 | 8 | 14 | 14 | 20 | 29 | 64 | 31 | 29 |
---|
Proceeds from assets held for sale | - | - | - | - | - | - | - | - | - | - | - | 12 | - |
---|
Business acquisitions, net of cash acquired | - | - | - | 6 | 73 | -1 | - | 125 | -0 | 37 | 419 | - | - |
---|
Investment in non-consolidated affiliate | - | - | - | - | - | - | - | - | - | 26 | - | - | - |
---|
Loan receivable from non-consolidated affiliate | - | - | - | - | - | - | - | - | - | - | 15 | - | - |
---|
Loan receivable from non-consolidated affiliate | - | - | - | - | - | - | - | - | - | - | 15 | - | - |
---|
Net cash provided by (used in) investing activities | -1 | -4 | -2 | - | - | - | - | - | -20 | -159 | -632 | 1 | 77 |
---|
Net cash provided by (used in) investing activities | -1 | -4 | -2 | - | - | - | - | - | -20 | -159 | -632 | 1 | 77 |
---|
Repayment of equipment financing obligations | - | - | - | - | - | - | - | - | 7 | 6 | 3 | 1 | - |
---|
Repayment of equipment financing obligations | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
---|
Repayment of term loan | - | - | - | - | - | - | - | - | 99 | 98 | - | - | - |
---|
Issuance of common stock, net | - | - | - | 34 | - | - | - | - | 11 | 20 | 15 | 13 | 5 |
---|
Cash flow hedge termination | - | - | - | - | - | - | - | - | - | 3 | - | - | - |
---|
Proceeds from Convertible Debt | - | - | - | - | - | - | - | - | - | 194 | 334 | - | - |
---|
Issuance of common stock, net | - | - | - | 34 | - | - | - | - | 11 | 20 | 15 | 13 | 5 |
---|
Premiums paid for capped call transactions | - | - | - | - | - | - | - | - | - | - | 29 | - | - |
---|
Proceeds from Convertible Debt | - | - | - | - | - | - | - | - | - | 194 | 334 | - | - |
---|
Proceeds From Equity Offering, Net | - | - | - | - | - | - | - | - | 161 | 127 | 408 | - | - |
---|
Premiums paid for capped call transactions | - | - | - | - | - | - | - | - | - | - | 29 | - | - |
---|
Net cash provided by financing activities | 2 | 3 | 3 | - | - | - | - | - | 159 | 236 | 725 | 12 | 5 |
---|
Proceeds From Equity Offering, Net | - | - | - | - | - | - | - | - | 161 | 127 | 408 | - | - |
---|
Net cash provided by financing activities | 2 | 3 | 3 | - | - | - | - | - | 159 | 236 | 725 | 12 | 5 |
---|
Net change in cash and cash equivalents | - | - | - | - | - | - | - | - | - | - | 66 | -54 | 79 |
---|
Interest paid | - | - | - | - | - | - | - | - | 5 | 3 | 3 | 3 | 3 |
---|
Income taxes paid, net | - | - | - | - | - | - | - | -0 | 0 | 0 | 0 | 0 | 0 |
---|
Fair Value Of Common Stock Issued To Fund Acquisition | - | - | - | - | 103 | - | - | 13 | - | - | 29 | - | - |
---|
Lease Obligation Incurred | 3 | 3 | 3 | 6 | 5 | 6 | 6 | 8 | 4 | 0 | - | - | - |
---|
Capital Expenditures Incurred but Not yet Paid | - | - | - | - | - | - | - | - | 1 | 2 | 1 | 2 | 1 |
---|
Capital Expenditures Incurred but Not yet Paid | - | - | - | - | - | - | - | - | 1 | 2 | 1 | 2 | 1 |
---|
Interest paid | - | - | - | - | - | - | - | - | 5 | 3 | 3 | 3 | 3 |
---|
Income taxes paid, net | - | - | - | - | - | - | - | -0 | 0 | 0 | 0 | 0 | 0 |
---|
Fair Value Of Common Stock Issued To Fund Acquisition | - | - | - | - | 103 | - | - | 13 | - | - | 29 | - | - |
---|
Lease Obligation Incurred | 3 | 3 | 3 | 6 | 5 | 6 | 6 | 8 | 4 | 0 | - | - | - |
---|
Capital Expenditures Incurred but Not yet Paid | - | - | - | - | - | - | - | - | 1 | 2 | 1 | 2 | 1 |
---|
Capital Expenditures Incurred but Not yet Paid | - | - | - | - | - | - | - | - | 1 | 2 | 1 | 2 | 1 |
---|